Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 22, 2006. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons regarding the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The material change reported is a transfer of 80,896 Ordinary Shares from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991. This transaction occurred on November 20, 2006, and was advised to the Company on November 21, 2006.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that the GSK Trust is a discretionary trust for current and former employees, and that three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) are interested in the shares held in the trust in the same capacity as other employees.
Investor Verification Checklist
- Verify the exact number of shares transferred (80,896) and the date of transfer (November 20, 2006).
- Confirm the specific employee share option plan involved (SmithKline Beecham Employee Share Option Plan 1991).
- Identify the directors with interests in the GSK Trust: Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop.
- Note that this filing does not impact the company's financial statements directly but relates to equity ownership distribution.